Literature DB >> 5852973

Immunogenicity and role of size: response of guinea pigs to oligotyrosine and tyrosine derivatives.

F Borek, Y Stupp, M Sela.   

Abstract

Guinea pigs injected with 100 micrograms of p-azobenzenearsonate derivatives of hexa-L-tyrosine, tri-L-tyrosine, or N-acetyl-L-tyrosine amide, in complete Freund's adjuvant, developed, after 10 to 19 days, delayed-type hypersensitivity to these substances. This was shown by skin reactions, followed by the formation of circulating antibodies that were detectable by passive cutaneous anaphylaxis. Experiments with p-azobenzenearsonate-hexa-L-tyrosine labeledwith iodine-131 showed that this substance was bound in vitro to proteins of normal guinea pig serum. Binding was similar with the nonantigenic hexa-L-tyrosine and its p-azobenzoate derivative.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5852973     DOI: 10.1126/science.150.3700.1177

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Immune and non-immune responses to monovalent low molecular weight penicilloyl-polylysines and penicilloyl-bacitracin in rabbits and guinea-pigs.

Authors:  A L De Weck; C H Schneider
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

2.  Antigens and antigenicity.

Authors:  M Sela
Journal:  Naturwissenschaften       Date:  1969-04

3.  The production and affinity of anti-hapten antibody under the influence of various inhibitory conditions.

Authors:  S Harel; S Ben-Efraim; P Liacopoulos
Journal:  Immunology       Date:  1970-08       Impact factor: 7.397

4.  Studies on the types of immune responses to synthetic antigens in guinea-pigs.

Authors:  Y Stupp; F Borek; M Sela
Journal:  Immunology       Date:  1966-12       Impact factor: 7.397

5.  Competition of haptens.

Authors:  A A Amkraut; J S Garvey; D H Campbell
Journal:  J Exp Med       Date:  1966-09-01       Impact factor: 14.307

6.  The immunogenicity of dinitrophenyl amino acids.

Authors:  J R Frey; A L de Weck; H Geleick; W Lergier
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.